Crisci, a member of the New York and New Jersey Bar associations, as well as a licensed CPA, has built a stellar career as a business legal executive across a number of regulated industries.
Recently, he has been General Counsel, COO, CFO, and controller for a publicly traded holding company, specialising in financial services and technology software companies.
Previously, he served as corporate counsel for a major health system with USD 1bn in annual revenues, and general counsel for a National Pharmacy Benefit Management company that includes mail and specialty drug dispensing.
Crisci brings a range of capabilities with his legal, business, financial, and regulatory background, and his expertise will be deployed to execute on the company's strategic objectives, including mergers and acquisitions, joint venture and development agreements, in-licensing and out-licensing agreements, and most importantly, long term supply and distributorship agreements for nation-wide pharmacy, laboratory, and medical management services.
Generex Biotechnology Corp., is a biopharmaceutical company that is actively involved in discovery, research, development, and financing of new compounds, therapies, diagnostics, delivery systems, and medical technologies.
ValiRx subsidiary Inaphaea extends drug repurposing deal with Dominion Biotech
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ
Sirum collaborates with Governor Wes Moore to expand medication access across Maryland